EVP & Chief Medical Officer · Karyopharm Therapeutics Inc. · Common Stock
Side
SELL
Value
$4,014
Shares
449
Price
$8.94
Executed
Apr 21, 2026
Disclosed
Apr 22, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 21 executedApr 22, 2026 disclosed
KPTI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rangwala Reshma filed this Form 4 reporting a open-market sale of KPTI on Apr 21, 2026. It became public on Apr 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP & Chief Medical Officer
Rangwala Reshmacik:0001825322
Issuer
Karyopharm Therapeutics Inc.cik:0001503802
Revision history · 0
No field has changed since this record was first ingested.
